Resalis Therapeutics
HealthcareBiotech & Pharma
HQ: Torino
Investors: 2
Biopharmaceutical company developing first-in-class RNA-targeted therapies for metabolic diseases, including obesity and NASH.
Investors (2)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Claris Ventures Sgr | Current | - | - | Website |
| LIFTT | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals